Status:
UNKNOWN
The Pandemic's Effect on Diagnosis and Treatment of Rectal Cancer
Lead Sponsor:
Sahlgrenska University Hospital
Conditions:
Rectal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Colorectal cancer is common with an annual prevalence of 6000. The majority can be cured and the five year survival rate is over 60%. In december 2019 reports came in about SARS-Cov-2, which later was...
Eligibility Criteria
Inclusion
- Rectal cancer diagnosis 2019-2022
Exclusion
- No rectal cancer diagnosis 2019-2022
Key Trial Info
Start Date :
February 15 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
8000 Patients enrolled
Trial Details
Trial ID
NCT05328960
Start Date
February 15 2022
End Date
December 31 2025
Last Update
December 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept. of Surgery, Sahlgrenska University Hospital/Ostra
Gothenburg, Sweden, SE 416 85